| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| checkmate 648 | 1.47 | 1 | 2026 | 16 | 13 |
| checkmate | 0.49 | 0.8 | 3825 | 99 | 9 |
| 648 | 1.84 | 0.3 | 2324 | 99 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| checkmate 648 | 0.49 | 0.6 | 9789 | 87 |
| checkmate 648 nejm | 1.82 | 0.2 | 7547 | 12 |
| checkmate 648 trial | 1.82 | 0.6 | 4707 | 54 |
| checkmate 648 study | 1.14 | 1 | 4191 | 79 |
| checkmate 648 pi | 0.52 | 0.7 | 8857 | 63 |
| checkmate 648 clinicaltrial.gov | 0.77 | 0.7 | 8573 | 98 |
| checkmate 648 pd-l1 | 1.51 | 0.7 | 5767 | 54 |
| checkmate 648 approval | 0.64 | 0.5 | 6529 | 29 |
| checkmate 648 2022 asco | 0.92 | 0.5 | 9841 | 57 |
| checkmate 648 ema approval | 1.3 | 0.5 | 4717 | 16 |
| checkmate 648 nivolumab | 0.23 | 0.5 | 5220 | 40 |
